MedinCell S.A. (EPA:MEDCL)
16.10
+0.23 (1.45%)
Aug 13, 2025, 5:35 PM CET
MedinCell Employees
MedinCell had 140 employees as of March 31, 2025. The number of employees increased by 6 or 4.48% compared to the previous year.
Employees
140
Change (1Y)
6
Growth (1Y)
4.48%
Revenue / Employee
$211,656
Profits / Employee
-$140,748
Market Cap
532.58M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 140 | 6 | 4.48% |
Mar 31, 2024 | 134 | 3 | 2.29% |
Mar 31, 2023 | 131 | -8 | -5.76% |
Mar 31, 2022 | 139 | 1 | 0.72% |
Mar 31, 2021 | 138 | 5 | 3.76% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
ABIVAX Société Anonyme | 69 |
Virbac | 6,365 |
MedinCell News
- 6 months ago - Teva Pharmaceuticals reports completion of phase 3 trial for Olanzapine LAI in Schizophrenia - Seeking Alpha